Successful organ transplantation from donors with Acinetobacter Baumannii septic shock

Transplantation

Volumn 81, Issue 6, 2006, Pages 853-855

  Cohen, Jonathan ^a,b,c   Michowiz, Rachael ^c   Ashkenazi, Tamar ^c   Pitlik, Silvio ^a   Singer, Pierre ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c National Transplant Center   (Israel)

Author keywords

Bacteremia; Organ donor; Septic shock

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; IMMUNOSUPPRESSIVE AGENT; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; CARDIAC GRAFT REJECTION; CATHETER INFECTION; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE COURSE; DONOR; FEMALE; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LABORATORY TEST; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MALE; ORGAN TRANSPLANTATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RECIPIENT; SEPTIC SHOCK; TREATMENT OUTCOME; URINARY TRACT INFECTION;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; PROSPECTIVE STUDIES; SHOCK, SEPTIC; TISSUE DONORS;

EID: 33645640909     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000203804.95180.6e     Document Type: Article

References (15)

1. Bull DA, Stahl RD, McMahan DL, et al. The high risk heart donor: potential pitfalls. J Heart Lung Transplant 1995; 14: 424.
2. Nelson PW, Delmonico FL, Tolkoff-Rubin NE, et al. Unsuspected donor pseudomonas infection causing arterial disruption after renal transplantation. Transplantation 1984; 37: 313.
3. Wood KE, Becker BN, McCartney JG, et al. Care of the potential organ donor. N Engl J Med 2004; 351: 2730.
4. Freeman R, Giatras I, Falagas ME, et al. Outcome of transplantation of organs procured from bacteremic donors. Transplantation 1999; 68: 1107.
5. Cisneros JM, Rodriguez-Bano J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect 2002; 8: 687.
6. Blot S, Vandewoude K, Colardyn F. Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study. Int Care Med 2003; 29: 471.
7. Chen HP, Chen TL, Lai CH, et al. Predictors of mortality in Acinetobacter baumannii bacteremia. J Microbiol Immunol Infect 2005; 38: 127.
8. Zibari GB, Lipka J, Zizzi H, et al. The use of contaminated donor organs in transplantation. Clin Transplant 2000; 14: 397.
9. Rubin RH, Fishman JA. A consideration of potential donors with active infection - is this a way to expand the donor pool? Transpl Int 1998; 11: 333.
10. Little DM, Farrel JG, Cunningham PM, Hickey DP. Donor sepsis is not a contraindication to cadaveric organ donation. Q J Med 1997; 90: 641.
11. Caballero F, Lopez-Navidad A, Domingo P, et al. Successful transplantation of organs retrieved from a donor with enterococcal endocarditis. Transpl Int 1998; 11: 387.
12. Lumbreras C, Sanz F, Gonzalez A, et al. Clinical significance of donor unrecognized bacteremia in the outcome of solid-organ transplant recipients. Clin Inf Dis 2001; 33: 722.
13. Opal SM, Palardy JE, Parejo, Jasman RL. Effect of anti-CD14 monoclonal antibody on clearance of Escherichia coli bacteremia and endotoxemia. Crit Care Med 2003; 31: 929.
14. Levy MM, Macias WL, Vincent JL, et al. Early changes in organ function predict eventual survival in severe sepsis. Crit Care Med 2005; 33: 2194.
15. Pauly RP, Rayner D, Murray AG, et al. Transplantation in the face of severe donor sepsis: pushing the boundaries? Am J Kidney Dis 2004; 44: E64.